Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ultrasound-Guided vs Non-Ultrasound-Guided Angio-Seal Vascular Hemosasis After Endovascular Treatment for Peripheral Artery Disease: An Observational Study.
Groenewegen FA, Charehbili A, Panfilov IA, Engels C, De Jong WJ, Burgmans M, Van der Bogt KEA, Eefting D, Van der Steenhoven TJ, Van der Linden E, Urlings T. Groenewegen FA, et al. Among authors: charehbili a. J Endovasc Ther. 2024 Dec 7:15266028241301278. doi: 10.1177/15266028241301278. Online ahead of print. J Endovasc Ther. 2024. PMID: 39644169 Free article.
[A large, purple swelling of the breast].
Charehbili A, CourrechStaal EFW, Pieters AMMJ. Charehbili A, et al. Ned Tijdschr Geneeskd. 2022 Oct 26;166:D6739. Ned Tijdschr Geneeskd. 2022. PMID: 36300433 Dutch.
Tumor-stroma ratio is associated with Miller-Payne score and pathological response to neoadjuvant chemotherapy in HER2-negative early breast cancer.
Hagenaars SC, de Groot S, Cohen D, Dekker TJA, Charehbili A, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, Pijl H, Putter H, Tollenaar RAEM, Kroep JR, Mesker WE; Dutch Breast Cancer Research Group (BOOG). Hagenaars SC, et al. Among authors: charehbili a. Int J Cancer. 2021 Sep 1;149(5):1181-1188. doi: 10.1002/ijc.33700. Epub 2021 Jun 5. Int J Cancer. 2021. PMID: 34043821 Free PMC article.
Estrogen Receptor Pathway Activity Score to Predict Clinical Response or Resistance to Neoadjuvant Endocrine Therapy in Primary Breast Cancer.
Inda MA, Blok EJ, Kuppen PJK, Charehbili A, den Biezen-Timmermans EC, van Brussel A, Fruytier SE, Meershoek-Klein Kranenbarg E, Kloet S, van der Burg B, Martens JWM, Sims AH, Turnbull AK, Dixon JM, Verhaegh W, Kroep JR, van de Velde CJH, van de Stolpe A. Inda MA, et al. Among authors: charehbili a. Mol Cancer Ther. 2020 Feb;19(2):680-689. doi: 10.1158/1535-7163.MCT-19-0318. Epub 2019 Nov 14. Mol Cancer Ther. 2020. PMID: 31727690
Cluster-randomized crossover trial of chlorhexidine-alcohol versus iodine-alcohol for prevention of surgical-site infection (SKINFECT trial).
Charehbili A, Koek MBG, de Mol van Otterloo JCA, Bronkhorst MWGA, van der Zwaal P, Thomassen B, Waasdorp EJ, Govaert JA, Bosman A, van den Bremer J, Ploeg AJ, Putter H, Meijs AP, van de Velde CJH, van Gijn W, Swijnenburg RJ. Charehbili A, et al. BJS Open. 2019 May 20;3(5):617-622. doi: 10.1002/bjs5.50177. eCollection 2019 Oct. BJS Open. 2019. PMID: 31592513 Free PMC article. Clinical Trial.
Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01).
de Groot S, Pijl H, Charehbili A, van de Ven S, Smit VTHBM, Meershoek-Klein Kranenbarg E, Heijns JB, van Warmerdam LJC, Kessels LW, Dercksen MW, Pepels MJAE, van Laarhoven HWM, Vriens BEPJ, Putter H, Fiocco M, Liefers GJ, van der Hoeven JJM, Nortier JWR, Kroep JR; Dutch Breast Cancer Research Group. de Groot S, et al. Among authors: charehbili a. Breast Cancer Res. 2019 Aug 28;21(1):97. doi: 10.1186/s13058-019-1180-6. Breast Cancer Res. 2019. PMID: 31455425 Free PMC article.
[A pulsatile mass on the forehead after a fall].
Schröder LBW, Charehbili A. Schröder LBW, et al. Among authors: charehbili a. Ned Tijdschr Geneeskd. 2019 May 24;163:D3835. Ned Tijdschr Geneeskd. 2019. PMID: 31166092 Dutch.
Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy.
de Groot AF, Blok EJ, Charehbili A, Engels CC, Smit VTHBM, Dekker-Ensink NG, Putter H, Meershoek-Klein Kranenbarg E, van de Velde CJH, Liefers GJ, Nortier JWR, Kuppen PJK, van der Burg SH, Kroep JR. de Groot AF, et al. Among authors: charehbili a. Breast Cancer Res Treat. 2019 Jun;175(3):605-615. doi: 10.1007/s10549-019-05195-y. Epub 2019 Mar 13. Breast Cancer Res Treat. 2019. PMID: 30868392 Free PMC article.
29 results